CL Stock Analysis — AI Buy/Sell Signals & Forecast
Real-time AI-powered analysis for CL with price targets, technical indicators (RSI, MACD, SMA), institutional money flow, and news-based signals.
Unlock Full Pro Analysis
Real-time alerts, price targets, institutional flow & more — one-time $19.95.
CL · Colgate-Palmolive Company
Free summary — full analysis below.
Colgate-Palmolive Company
Pre-Market & After Hours is Pro Only
Upgrade to unlock this and all premium features
Oct 9, 08:11 PM
Confidence Score is Pro Only
Upgrade to unlock this and all premium features
Optimal Buy & Sell Zones is Pro Only
Upgrade to unlock this and all premium features
Strong Uptrend — Price above SMA50 & SMA200, Golden Cross
Total Conviction Scorecard is Pro Only
Upgrade to unlock this and all premium features
Optimal Buy & Sell Zones is Pro Only
Upgrade to unlock this and all premium features
$-27.88 (-23.3%) from high
Day's Range: $90.01 – $92.17
+$36.62 (+66.6%) above low
▲ Above — short-term uptrend (bullish)
▲ Above — long-term uptrend (bullish)
📉 0.6x avg — below normal, treat signals with caution
📉 Below normal — thin market, price moves may not hold
RSI, MACD & SMA based on daily closes — update at market close. Live price shown separately.
Institutional Money Flow is Pro Only
Upgrade to unlock this and all premium features
Phantom Flow is Pro Only
Upgrade to unlock this and all premium features
Smart Money Flow Index is Pro Only
Upgrade to unlock this and all premium features
Risk Score is Pro Only
Upgrade to unlock this and all premium features
Colgate-Palmolive maintains a strong reputation among hedge funds as a reliable Dividend King with consistent growth potential. Recent analyst adjustments remain bullish, keeping price targets elevated despite minor fluctuations.
Latest News & Market Impact
Saudi Aramco reportedly restores full crude oil supply to Europe for November
Canadian dollar slides after surprise job losses, rate hike bets retreat
Hedge Funds Think Colgate-Palmolive Is One of the Best Dividend King Stocks To Buy
BofA Adjusts Price Target on Colgate-Palmolive to $100 From $102, Keeps Buy Rating
Gold prices hit one-week high, investors eye Fed rate trajectory
Disclaimer: This analysis is AI-generated and should not be considered financial advice. Always consult a qualified financial advisor before making investment decisions.
CL Stock Analysis — Frequently Asked Questions
Is CL a buy or sell right now?▾
Our AI engine analyzes CL across technicals (RSI, MACD, SMA50/200), institutional money flow (OBV, SEC 13D/13G filings), news sentiment, and price action to produce a real-time buy/sell signal with a confidence score. The recommendation updates every time the analysis runs.
What is the price target for CL?▾
The analysis calculates optimal entry and exit price targets for CL using support/resistance levels, moving-average structure, and momentum. These levels are dynamic and recompute as new market data arrives.
What do the RSI and MACD signals say about CL?▾
RSI measures whether CL is overbought or oversold; MACD shows momentum and trend shifts. A bullish MACD crossover with RSI below 70 often signals continued upside, while divergence can warn of a reversal.
Are institutions buying CL?▾
We track institutional positioning in CL through On-Balance Volume (OBV) money flow and SEC Schedule 13D/13G filings — the same disclosures activist investors and large funds must file. Rising OBV plus new 13D filings typically indicate smart-money accumulation.
What are the main risks of investing in CL?▾
Key risks for CL include valuation compression, sector rotation, earnings volatility, and macro factors such as rates and inflation. The analysis grades risk from very low to very high based on volatility, drawdown history, and beta.
How accurate is the CL AI analysis?▾
The CL analysis combines real-time market data, technical indicators, institutional flow, and news-based sentiment. It is a decision-support tool, not financial advice — always do your own research and consider your risk tolerance before investing.
Market Intelligence provides AI-powered stock & ETF analysis for informational purposes only and does not constitute financial advice.